Radius Health, Inc.RDUS saw a big move last session, as the company's shares fell by over 12% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for RDUS, as the stock is now down nearly 31% since Jan 4.
This slump shouldn't be too much of a surprise to investors, as the biopharmaceutical company has seen 1 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 60 days. This suggests there may be more trouble down the road.
So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
RDUS currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00.
A better-ranked stock in the retail sector is Aerie Pharmaceuticals, Inc. AERI , which currently carries a Zacks Rank #1 (Strong Buy).
Is RDUS going up? Or down? Predict to see what others think: